Hansma International SPRL
Hansma International reported total assets of 75,376 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Mar 2026).
The score of Hansma International shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -28 % Total assets -29 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hansma International's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Mar 2026
- Year ended 31 Dec 2024filed on 02 Jul 2025
- Year ended 31 Dec 2023filed on 27 Aug 2024
- Year ended 31 Dec 2022filed on 22 May 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Hansma International's financial analysis
- Solvency63.3%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hansma International
Hansma International's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0457.552.364
- VAT number
- BE0457552364
- Peppol
- Registered · 0208:0457552364 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 01 Apr 1996
- Registered office
- 2820 Bonheiden
- Latest accounts
- 2025 · filed on 17 Mar 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Hansma International (SPRL) has been based in Bonheiden since 1996, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 8,992 € and equity of 47,746 €; its revenue is not published. Its solvency stands at 63.3%, above the median of its sector (56.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Hansma International
Companies in the same business, of comparable size and area, outside its group.
- Asclepia MedChem Solutions Manufacture of basic pharmaceutical products Destelbergen · balance sheet 360,741 €
- MDT Services & Technologies Manufacture of basic pharmaceutical products Lontzen · balance sheet 102,386 €
- Lanceo Manufacture of basic pharmaceutical products Vorselaar · balance sheet 291,955 €
- MC Pharma Manufacture of basic pharmaceutical products Beaumont · balance sheet 28,699 €
- E.J.L. ExAct Manufacture of basic pharmaceutical products Ostend · balance sheet 59,234 €
- Chris Pharma Works Manufacture of basic pharmaceutical products Profondeville · balance sheet 24,086 €
- Harika Lifij Manufacture of basic pharmaceutical products Evere · balance sheet 105,370 €
- Evarmed Manufacture of basic pharmaceutical products Diepenbeek · balance sheet 51,346 €
Frequently asked questions about Hansma International
What is the revenue of Hansma International?
Hansma International files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Hansma International?
In Belgium, the VAT number is the company number prefixed with BE: BE0457552364 for Hansma International, if the company is VAT-registered. Its company number (CBE) is 0457.552.364.
Where is the registered office of Hansma International?
According to the CBE register, the registered office of Hansma International is in 2820 Bonheiden.
What is the equity of Hansma International?
At the close of the 2025 financial year, the equity of Hansma International amounts to 47,746 €, a solvency of 63.3% of total assets.
Who manages Hansma International?
The register lists 1 active mandates at Hansma International. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hansma International
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →